Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial.
暂无分享,去创建一个
Z. Ram | J. Martin | M. Westphal | S. Ylä-Herttuala | P. Warnke | P. Menei | R. Kay | D. Eckland | J. Kinley